Tom Lue
Dr. Tom F. Lue graduated with highest honors from Kaohsiung Medical College, in Kaohsiung City, Taiwan in 1972. After completing his urologic training at Downstate Medical Center in Brooklyn, New York he was awarded the Valentine Fellowship from the New York Academy of Medicine to pursue studies of neurophysiology of the genitourinary tract at the University of California, San Francisco (UCSF) in 1981. Currently, he is Professor of Urology, Emil Tanagho Endowed Chair in Clinical Urology, Founder and Director of the Knuppe Molecular Urology lab. at the University of California, San Francisco.
Besides urological surgical practice, Dr. Lue continued to pursue basic and clinical research throughout his career. In basic research, his team discovered the anatomical and hemodynamic mechanisms of venous occlusion that are essential for achieving and maintaining penile erection. His team isolated “pure” erection nerves in dogs and monkeys and obtained a USA patent “erection pacemaker”. His team also developed various animal models for vasculogenic and neurogenic erectile dysfunction, Peyronie’s disease, overactive and underactive bladder, and urinary incontinence. He was the third urologist to receive a MERIT grant award from the NIH for his outstanding research. He continued to have NIH support up to the present. Dr. Lue's current basic science research projects involve the development of a non-invasive stem/progenitor cell therapy for various diseases including erectile dysfunction, overactive bladder, incontinence, infertility, nerve and muscle injury, and degenerative diseases.
In clinical practice, he is a well-respected urologic surgeon and has been invited to share his experience with colleagues all over the world. He introduced duplex ultrasound and penile injection and stimulation test which have become the gold standard for the diagnosis of vasculogenic ED, Peyronie’s disease, and priapism. He developed 4 surgical procedures for Peyronie’s disease: 16 dots plication procedure, H-incision with saphenous vein graft; extra-tunical grafting for hourglass deformity, and subtunical excision of ossified plaques. He also developed 3 novel treatments for 3 types of priapisms: T shunt + perioperative anticoagulation for prolonged ischemic priapism, antiandrogen for high flow priapism and intracavernous Botox for recurrent priapism. For problems that may occur with implantation of a penile prosthesis, he introduced transglanular fixation for deviated cylinder tip and a plication technique to correct deformity prior to cylinder implantation.
Dr. Lue has been the recipient of the American Urological Association's Gold Cystoscope Award, Presidential Citation, John Latimore Lecturer, and the American Foundation of Urological Diseases’ Most Innovative Researcher Award as well as the Distinguished Alumnus Award. He also received the Valentine Medal from the New York Academy of Medicine. He chaired the International Consultation on Sexual Medicine held in Paris in July 2003, serving as the lead author of its published proceedings. He was the honorary president of the same meeting in Paris in July 2009. Besides being listed in the Best Doctors in America and America’s Top Doctors for many years, Dr. Lue was named one of the 8 top doctors for men by Men’s Health Magazine in 2003. In 2009 Dr. Lue received an Honorary Doctor of Science Degree for his contribution to science from Downstate Medical School, the State University of New York. His most recent accolade is the Spence Medal Award from the American Association of Genitourinary Surgeons in April 2025.
He has published more than 500 peer-reviewed articles and written more than 100 book chapters. He is the editor-in-chief of Translational Andrology and Urology. His team has trained more than 70 postgraduate doctors from many countries.
15th August 2025
| Time | Session |
|---|---|
|
08:30
10:00
|
TICC - 3F Banquet Hall
|